Quibim has launched QP-Breast, a CE-marked and UKCA-marked AI tool that automatically detects suspected lesions on breast MRI, across Europe and the U.K.
The tool assists radiologists by highlighting suspicious areas and generating structured reports including lesion size, volume, location, and likelihood of malignancy, integrating directly into existing hospital systems. It is suitable for both screening and diagnostic breast MRI, Quibim said.
QP-Breast is CE marked under EU MDR 2017/745 as a Class IIb medical device and UKCA marked as a Class IIa device, and is available to hospitals, screening programs, and specialist imaging centers across Europe and the U.K.
